On the recordMarch 18, 2013
Additionally, the U.S. bio-pharmaceutical industry has had several patents disregarded, just disregarded, due to inappropriate use of compulsory licensing and patent revocation.
Source
congress.govEditor's note · Context
Carper highlights issues with patent rights for U.S. bio-pharmaceuticals in India.
Share
More from Tom Carper
Jun 18, 2024
No. The bill simply allows the Secretaries of Energy and State to explore pathways to grant generally authorized status to countries other than having 123 agreements in place. The bill does not relieve those Secretaries of their statutory…
Jul 25, 2024
To have vacancies that may be not just months, but in some cases years to that have been filled, that justice delayed is justice denied.
Jun 18, 2024
The ADVANCE Act has no effect on the current authorities of the Commission, the Secretaries of Energy, State, or any other Federal Agency involved in the export of nuclear technology. The notification in section 103 exists in addition to…
Dec 11, 2024
I just want to take a moment, if I could, to thank my family Martha, who is seated right up here to my right. And over the years, I have spoken with members of the Armed Forces who are married, and I have not only thanked them for their…
Other voices in this conversation
